February 28, 2024 / 12:05 PM IST
Reported Standalone quarterly numbers for Bandaram Pharma Packtech are:Net Sales at Rs 5.70 crore in December 2023 up 411.55% from Rs. 1.12 crore in December 2022.
Story continues below Advertisement
Quarterly Net Profit at Rs. 0.05 crore in December 2023 down 41.57% from Rs. 0.09 crore in December 2022.
EBITDA stands at Rs. 0.07 crore in December 2023 down 22.22% from Rs. 0.09 crore in December 2022.
Bandaram Pharma EPS has decreased to Rs. 0.04 in December 2023 from Rs. 0.29 in December 2022.
Bandaram Pharma shares closed at 31.88 on February 26, 2024 (BSE) and has given 14.51% returns over the last 6 months and -56.30% over the last 12 months.
| Bandaram Pharma Packtech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 5.70 | 3.54 | 1.12 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 5.70 | 3.54 | 1.12 | | EXPENDITURE | | Consumption of Raw Materials | 6.04 | 2.86 | 1.02 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -0.67 | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.22 | 0.39 | 0.01 | | Depreciation | 0.00 | 0.00 | -- | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 0.05 | 0.23 | -- | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.07 | 0.05 | 0.09 | | Other Income | -- | -- | -- | | P/L Before Int., Excpt. Items & Tax | 0.07 | 0.05 | 0.09 | | Interest | -- | -- | -- | | P/L Before Exceptional Items & Tax | 0.07 | 0.05 | 0.09 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.07 | 0.05 | 0.09 | | Tax | 0.02 | -- | -- | | P/L After Tax from Ordinary Activities | 0.05 | 0.05 | 0.09 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.05 | 0.05 | 0.09 | | Equity Share Capital | 12.00 | 12.00 | 3.00 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.04 | 0.05 | 0.29 | | Diluted EPS | 0.04 | 0.05 | 0.29 | | EPS After Extra Ordinary | | Basic EPS | 0.04 | 0.05 | 0.29 | | Diluted EPS | 0.04 | 0.05 | 0.29 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|